Results from first-in-human study of [11C]SMW-139 as an in vivo neuroinflammation tracer in MS March 12, 2020
New phase I trial studies imaging agent I-124 M5A to detect liver metastases from colorectal cancer March 5, 2020
Blue Earth begins phase III imaging study with rhPSMA 7.3 (18F) in newly diagnosed prostate cancer March 2, 2020
New MRI contrast agent specifically targeting CXCR4 in liver metastases may allow early detection Feb. 27, 2020
RSS